BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28972702)

  • 1. Survival outcomes for patients with localised upper tract urothelial carcinoma managed with non-definitive treatment.
    Syed JS; Nguyen KA; Suarez-Sarmiento A; Johnson K; Leapman MS; Raman JD; Shuch B
    BJU Int; 2018 Jan; 121(1):124-129. PubMed ID: 28972702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients.
    Lughezzani G; Jeldres C; Isbarn H; Sun M; Shariat SF; Alasker A; Pharand D; Widmer H; Arjane P; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    Eur J Cancer; 2009 Dec; 45(18):3291-7. PubMed ID: 19615885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic versus laparoscopic management of noninvasive upper tract urothelial carcinoma: 20-year single center experience.
    Cutress ML; Stewart GD; Tudor EC; Egong EA; Wells-Cole S; Phipps S; Thomas BG; Riddick AC; McNeill SA; Tolley DA
    J Urol; 2013 Jun; 189(6):2054-60. PubMed ID: 23228378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of upper tract urothelial cancer managed non-surgically.
    Syed JS; Nguyen KA; Suarez-Sariemento A; Leung C; Casilla-Lennon M; Raman JD; Shuch B
    Can J Urol; 2019 Apr; 26(2):9699-9707. PubMed ID: 31012833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prognostic nomogram for the cancer-specific survival of patients with upper-tract urothelial carcinoma based on the Surveillance, Epidemiology, and End Results Database.
    Li C; Yang J; Xu F; Han D; Zheng S; Kaaya RE; Wang S; Lyu J
    BMC Cancer; 2020 Jun; 20(1):534. PubMed ID: 32513124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database.
    Lughezzani G; Sun M; Perrotte P; Shariat SF; Jeldres C; Budäus L; Latour M; Widmer H; Duclos A; Bénard F; McCormack M; Montorsi F; Karakiewicz PI
    Urology; 2010 Feb; 75(2):321-7. PubMed ID: 19962727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degree of hydronephrosis predicts adverse pathological features and worse oncologic outcomes in patients with high-grade urothelial carcinoma of the upper urinary tract.
    Chung PH; Krabbe LM; Darwish OM; Westerman ME; Bagrodia A; Gayed BA; Haddad AQ; Kapur P; Sagalowsky AI; Lotan Y; Margulis V
    Urol Oncol; 2014 Oct; 32(7):981-8. PubMed ID: 25022858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes mellitus without metformin intake is associated with worse oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
    Rieken M; Xylinas E; Kluth L; Trinh QD; Lee RK; Fajkovic H; Novara G; Margulis V; Lotan Y; Martinez-Salamanca JI; Matsumoto K; Seitz C; Remzi M; Karakiewicz PI; Scherr DS; Briganti A; Kautzky-Willer A; Bachmann A; Shariat SF;
    Eur J Surg Oncol; 2014 Jan; 40(1):113-20. PubMed ID: 24113620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laparoscopic radical nephroureterectomy is associated with worse survival outcomes than open radical nephroureterectomy in patients with locally advanced upper tract urothelial carcinoma.
    Kim HS; Ku JH; Jeong CW; Kwak C; Kim HH
    World J Urol; 2016 Jun; 34(6):859-69. PubMed ID: 26497823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two cycles of neoadjuvant chemotherapy improves survival in patients with high-risk upper tract urothelial carcinoma.
    Zennami K; Sumitomo M; Takahara K; Nukaya T; Takenaka M; Fukaya K; Ichino M; Fukami N; Sasaki H; Kusaka M; Shiroki R
    BJU Int; 2021 Mar; 127(3):332-339. PubMed ID: 32896105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal stage and grade migration in surgically treated patients with upper tract urothelial carcinoma.
    Lughezzani G; Jeldres C; Isbarn H; Sun M; Shariat SF; Widmer H; Arjane P; Graefen M; Perrotte P; Montorsi F; Karakiewicz PI
    BJU Int; 2010 Mar; 105(6):799-804. PubMed ID: 19725824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rates of lymph node invasion and their impact on cancer specific mortality in upper urinary tract urothelial carcinoma.
    Nazzani S; Mazzone E; Preisser F; Tian Z; Mistretta FA; Shariat SF; Montanari E; Acquati P; Briganti A; Saad F; Carmignani L; Karakiewicz PI
    Eur J Surg Oncol; 2019 Jul; 45(7):1238-1245. PubMed ID: 30563773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncologic Outcomes Following Robot-Assisted Laparoscopic Nephroureterectomy with Bladder Cuff Excision for Upper Tract Urothelial Carcinoma.
    Aboumohamed AA; Krane LS; Hemal AK
    J Urol; 2015 Dec; 194(6):1561-6. PubMed ID: 26192256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph node yield and tumor location in patients with upper tract urothelial carcinoma undergoing nephroureterectomy affects survival: A U.S. population-based analysis (2004-2012).
    Chappidi MR; Kates M; Johnson MH; Hahn NM; Bivalacqua TJ; Pierorazio PM
    Urol Oncol; 2016 Dec; 34(12):531.e15-531.e24. PubMed ID: 27476032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment strategies for upper tract urothelial carcinoma (UTUC) of a solitary kidney: a single-institutional analysis of 61 cases.
    Su X; Fang D; Zhang L; Xiong G; Hao H; Zhao G; Yang K; Xing Y; Li X; Zhou L
    Int Urol Nephrol; 2016 Oct; 48(10):1601-8. PubMed ID: 27376898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival effect of perioperative systemic chemotherapy on overall mortality in locally advanced and/or positive regional lymph node non-metastatic urothelial carcinoma of the upper urinary tract.
    Nazzani S; Preisser F; Mazzone E; Tian Z; Mistretta FA; Shariat SF; Soulières D; Saad F; Montanari E; Luzzago S; Briganti A; Carmignani L; Karakiewicz PI
    World J Urol; 2019 Jul; 37(7):1329-1337. PubMed ID: 30298285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urothelial Carcinoma of the Renal Pelvis and Ureter: Does Location Make a Difference?
    Lwin AA; Hsu CH; Chipollini J
    Clin Genitourin Cancer; 2020 Feb; 18(1):45-49.e1. PubMed ID: 31786118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinicopathologic characteristics and prognosis of upper tract urothelial carcinoma: an analysis of 368 radical nephroureterectomy specimens].
    Wang Y; He HY
    Zhonghua Bing Li Xue Za Zhi; 2016 Oct; 45(10):681-686. PubMed ID: 27760608
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment Patterns, Outcomes, and Costs Associated With Localized Upper Tract Urothelial Carcinoma.
    Fero KE; Shan Y; Lec PM; Sharma V; Srinivasan A; Movva G; Baillargeon J; Chamie K; Williams SB
    JNCI Cancer Spectr; 2021 Dec; 5(6):. PubMed ID: 34805743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience.
    Cutress ML; Stewart GD; Wells-Cole S; Phipps S; Thomas BG; Tolley DA
    BJU Int; 2012 Dec; 110(11):1608-17. PubMed ID: 22564677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.